nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—CYP1A2—Carmustine—lymphatic system cancer	0.115	0.168	CbGbCtD
Nortriptyline—CYP3A5—Teniposide—lymphatic system cancer	0.104	0.152	CbGbCtD
Nortriptyline—CYP2E1—Mitoxantrone—lymphatic system cancer	0.0933	0.137	CbGbCtD
Nortriptyline—CYP2C19—Teniposide—lymphatic system cancer	0.0836	0.123	CbGbCtD
Nortriptyline—CYP2C9—Teniposide—lymphatic system cancer	0.0695	0.102	CbGbCtD
Nortriptyline—CYP3A5—Vincristine—lymphatic system cancer	0.0499	0.0732	CbGbCtD
Nortriptyline—CYP3A4—Cytarabine—lymphatic system cancer	0.041	0.0602	CbGbCtD
Nortriptyline—CYP3A4—Teniposide—lymphatic system cancer	0.0404	0.0593	CbGbCtD
Nortriptyline—ALB—Methotrexate—lymphatic system cancer	0.0376	0.0551	CbGbCtD
Nortriptyline—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0283	0.0415	CbGbCtD
Nortriptyline—CYP3A4—Vincristine—lymphatic system cancer	0.0195	0.0285	CbGbCtD
Nortriptyline—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00125	0.00393	CcSEcCtD
Nortriptyline—Tachycardia—Teniposide—lymphatic system cancer	0.00125	0.00392	CcSEcCtD
Nortriptyline—Malaise—Fludarabine—lymphatic system cancer	0.00124	0.0039	CcSEcCtD
Nortriptyline—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00123	0.00388	CcSEcCtD
Nortriptyline—Leukopenia—Fludarabine—lymphatic system cancer	0.00123	0.00387	CcSEcCtD
Nortriptyline—Pruritus—Mechlorethamine—lymphatic system cancer	0.00123	0.00385	CcSEcCtD
Nortriptyline—Anorexia—Teniposide—lymphatic system cancer	0.00122	0.00383	CcSEcCtD
Nortriptyline—Pancytopenia—Carmustine—lymphatic system cancer	0.0012	0.00377	CcSEcCtD
Nortriptyline—Hypotension—Teniposide—lymphatic system cancer	0.00119	0.00375	CcSEcCtD
Nortriptyline—Convulsion—Fludarabine—lymphatic system cancer	0.00119	0.00375	CcSEcCtD
Nortriptyline—Gingivitis—Methotrexate—lymphatic system cancer	0.00119	0.00374	CcSEcCtD
Nortriptyline—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00119	0.00373	CcSEcCtD
Nortriptyline—Discomfort—Fludarabine—lymphatic system cancer	0.00116	0.00364	CcSEcCtD
Nortriptyline—Hypoaesthesia—Bleomycin—lymphatic system cancer	0.00115	0.00362	CcSEcCtD
Nortriptyline—Pancytopenia—Vincristine—lymphatic system cancer	0.00115	0.0036	CcSEcCtD
Nortriptyline—Sweating increased—Mitoxantrone—lymphatic system cancer	0.00114	0.0036	CcSEcCtD
Nortriptyline—Petechiae—Methotrexate—lymphatic system cancer	0.00113	0.00356	CcSEcCtD
Nortriptyline—Confusional state—Fludarabine—lymphatic system cancer	0.00113	0.00356	CcSEcCtD
Nortriptyline—Oedema—Fludarabine—lymphatic system cancer	0.00112	0.00353	CcSEcCtD
Nortriptyline—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00112	0.00351	CcSEcCtD
Nortriptyline—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00111	0.00349	CcSEcCtD
Nortriptyline—Decreased appetite—Teniposide—lymphatic system cancer	0.00111	0.00349	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Carmustine—lymphatic system cancer	0.0011	0.00347	CcSEcCtD
Nortriptyline—Vomiting—Mechlorethamine—lymphatic system cancer	0.0011	0.00346	CcSEcCtD
Nortriptyline—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0011	0.00345	CcSEcCtD
Nortriptyline—Stomatitis—Carmustine—lymphatic system cancer	0.0011	0.00345	CcSEcCtD
Nortriptyline—Rash—Mechlorethamine—lymphatic system cancer	0.00109	0.00343	CcSEcCtD
Nortriptyline—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00109	0.00343	CcSEcCtD
Nortriptyline—Weight decreased—Vincristine—lymphatic system cancer	0.00109	0.00343	CcSEcCtD
Nortriptyline—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00109	0.00341	CcSEcCtD
Nortriptyline—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00108	0.0034	CcSEcCtD
Nortriptyline—Flushing—Bleomycin—lymphatic system cancer	0.00108	0.00338	CcSEcCtD
Nortriptyline—Anorexia—Fludarabine—lymphatic system cancer	0.00107	0.00336	CcSEcCtD
Nortriptyline—Weight increased—Mitoxantrone—lymphatic system cancer	0.00107	0.00336	CcSEcCtD
Nortriptyline—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00106	0.00334	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Vincristine—lymphatic system cancer	0.00106	0.00333	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.00105	0.00331	CcSEcCtD
Nortriptyline—Myocardial infarction—Vincristine—lymphatic system cancer	0.00105	0.00331	CcSEcCtD
Nortriptyline—Feeling abnormal—Teniposide—lymphatic system cancer	0.00105	0.00331	CcSEcCtD
Nortriptyline—Stomatitis—Vincristine—lymphatic system cancer	0.00105	0.00329	CcSEcCtD
Nortriptyline—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00105	0.00329	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Mitoxantrone—lymphatic system cancer	0.00103	0.00324	CcSEcCtD
Nortriptyline—Sweating—Vincristine—lymphatic system cancer	0.00103	0.00324	CcSEcCtD
Nortriptyline—Nausea—Mechlorethamine—lymphatic system cancer	0.00103	0.00323	CcSEcCtD
Nortriptyline—Myocardial infarction—Mitoxantrone—lymphatic system cancer	0.00103	0.00323	CcSEcCtD
Nortriptyline—Alopecia—Bleomycin—lymphatic system cancer	0.00102	0.00322	CcSEcCtD
Nortriptyline—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00102	0.00321	CcSEcCtD
Nortriptyline—Jaundice—Mitoxantrone—lymphatic system cancer	0.00102	0.00321	CcSEcCtD
Nortriptyline—Urticaria—Teniposide—lymphatic system cancer	0.00101	0.00319	CcSEcCtD
Nortriptyline—Body temperature increased—Teniposide—lymphatic system cancer	0.00101	0.00317	CcSEcCtD
Nortriptyline—Abdominal pain—Teniposide—lymphatic system cancer	0.00101	0.00317	CcSEcCtD
Nortriptyline—Paraesthesia—Fludarabine—lymphatic system cancer	0.00101	0.00317	CcSEcCtD
Nortriptyline—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00101	0.00316	CcSEcCtD
Nortriptyline—Hallucination—Carmustine—lymphatic system cancer	0.00101	0.00316	CcSEcCtD
Nortriptyline—Sweating—Mitoxantrone—lymphatic system cancer	0.001	0.00316	CcSEcCtD
Nortriptyline—Oedema peripheral—Carmustine—lymphatic system cancer	0.000996	0.00313	CcSEcCtD
Nortriptyline—Dyspepsia—Fludarabine—lymphatic system cancer	0.000988	0.00311	CcSEcCtD
Nortriptyline—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000977	0.00307	CcSEcCtD
Nortriptyline—Decreased appetite—Fludarabine—lymphatic system cancer	0.000976	0.00307	CcSEcCtD
Nortriptyline—Fatigue—Fludarabine—lymphatic system cancer	0.000968	0.00304	CcSEcCtD
Nortriptyline—Hallucination—Vincristine—lymphatic system cancer	0.000961	0.00302	CcSEcCtD
Nortriptyline—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000961	0.00302	CcSEcCtD
Nortriptyline—Constipation—Fludarabine—lymphatic system cancer	0.00096	0.00302	CcSEcCtD
Nortriptyline—Eye disorder—Carmustine—lymphatic system cancer	0.000945	0.00297	CcSEcCtD
Nortriptyline—Hypersensitivity—Teniposide—lymphatic system cancer	0.000941	0.00296	CcSEcCtD
Nortriptyline—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00094	0.00296	CcSEcCtD
Nortriptyline—Flushing—Carmustine—lymphatic system cancer	0.000939	0.00295	CcSEcCtD
Nortriptyline—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000936	0.00294	CcSEcCtD
Nortriptyline—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000925	0.00291	CcSEcCtD
Nortriptyline—Asthenia—Teniposide—lymphatic system cancer	0.000917	0.00288	CcSEcCtD
Nortriptyline—Malaise—Bleomycin—lymphatic system cancer	0.00091	0.00286	CcSEcCtD
Nortriptyline—Pruritus—Teniposide—lymphatic system cancer	0.000904	0.00284	CcSEcCtD
Nortriptyline—Arrhythmia—Carmustine—lymphatic system cancer	0.000904	0.00284	CcSEcCtD
Nortriptyline—Leukopenia—Bleomycin—lymphatic system cancer	0.000903	0.00284	CcSEcCtD
Nortriptyline—Alopecia—Carmustine—lymphatic system cancer	0.000894	0.00281	CcSEcCtD
Nortriptyline—Body temperature increased—Fludarabine—lymphatic system cancer	0.000888	0.00279	CcSEcCtD
Nortriptyline—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000876	0.00275	CcSEcCtD
Nortriptyline—Diarrhoea—Teniposide—lymphatic system cancer	0.000874	0.00275	CcSEcCtD
Nortriptyline—Alopecia—Vincristine—lymphatic system cancer	0.000853	0.00268	CcSEcCtD
Nortriptyline—Discomfort—Bleomycin—lymphatic system cancer	0.000848	0.00267	CcSEcCtD
Nortriptyline—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00084	0.00264	CcSEcCtD
Nortriptyline—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000835	0.00262	CcSEcCtD
Nortriptyline—Alopecia—Mitoxantrone—lymphatic system cancer	0.000831	0.00261	CcSEcCtD
Nortriptyline—Confusional state—Bleomycin—lymphatic system cancer	0.00083	0.00261	CcSEcCtD
Nortriptyline—Vision blurred—Carmustine—lymphatic system cancer	0.00083	0.00261	CcSEcCtD
Nortriptyline—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000827	0.0026	CcSEcCtD
Nortriptyline—Tremor—Carmustine—lymphatic system cancer	0.000825	0.00259	CcSEcCtD
Nortriptyline—Oedema—Bleomycin—lymphatic system cancer	0.000823	0.00259	CcSEcCtD
Nortriptyline—Vomiting—Teniposide—lymphatic system cancer	0.000812	0.00255	CcSEcCtD
Nortriptyline—Agitation—Carmustine—lymphatic system cancer	0.000809	0.00254	CcSEcCtD
Nortriptyline—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000806	0.00253	CcSEcCtD
Nortriptyline—Asthenia—Fludarabine—lymphatic system cancer	0.000806	0.00253	CcSEcCtD
Nortriptyline—Rash—Teniposide—lymphatic system cancer	0.000805	0.00253	CcSEcCtD
Nortriptyline—Dermatitis—Teniposide—lymphatic system cancer	0.000805	0.00253	CcSEcCtD
Nortriptyline—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000802	0.00252	CcSEcCtD
Nortriptyline—Headache—Teniposide—lymphatic system cancer	0.0008	0.00252	CcSEcCtD
Nortriptyline—Pruritus—Fludarabine—lymphatic system cancer	0.000794	0.0025	CcSEcCtD
Nortriptyline—Leukopenia—Carmustine—lymphatic system cancer	0.000788	0.00248	CcSEcCtD
Nortriptyline—Anorexia—Bleomycin—lymphatic system cancer	0.000785	0.00247	CcSEcCtD
Nortriptyline—Agitation—Vincristine—lymphatic system cancer	0.000772	0.00243	CcSEcCtD
Nortriptyline—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000771	0.00242	CcSEcCtD
Nortriptyline—Hypotension—Bleomycin—lymphatic system cancer	0.000769	0.00242	CcSEcCtD
Nortriptyline—Diarrhoea—Fludarabine—lymphatic system cancer	0.000768	0.00241	CcSEcCtD
Nortriptyline—Convulsion—Carmustine—lymphatic system cancer	0.000763	0.0024	CcSEcCtD
Nortriptyline—Hypertension—Carmustine—lymphatic system cancer	0.00076	0.00239	CcSEcCtD
Nortriptyline—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000759	0.00239	CcSEcCtD
Nortriptyline—Nausea—Teniposide—lymphatic system cancer	0.000759	0.00238	CcSEcCtD
Nortriptyline—Leukopenia—Vincristine—lymphatic system cancer	0.000752	0.00236	CcSEcCtD
Nortriptyline—Anxiety—Carmustine—lymphatic system cancer	0.000747	0.00235	CcSEcCtD
Nortriptyline—Paraesthesia—Bleomycin—lymphatic system cancer	0.000739	0.00232	CcSEcCtD
Nortriptyline—Malaise—Mitoxantrone—lymphatic system cancer	0.000738	0.00232	CcSEcCtD
Nortriptyline—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000733	0.0023	CcSEcCtD
Nortriptyline—Convulsion—Vincristine—lymphatic system cancer	0.000728	0.00229	CcSEcCtD
Nortriptyline—Hypertension—Vincristine—lymphatic system cancer	0.000726	0.00228	CcSEcCtD
Nortriptyline—Confusional state—Carmustine—lymphatic system cancer	0.000725	0.00228	CcSEcCtD
Nortriptyline—Oedema—Carmustine—lymphatic system cancer	0.000719	0.00226	CcSEcCtD
Nortriptyline—Decreased appetite—Bleomycin—lymphatic system cancer	0.000716	0.00225	CcSEcCtD
Nortriptyline—Vomiting—Fludarabine—lymphatic system cancer	0.000714	0.00224	CcSEcCtD
Nortriptyline—Convulsion—Mitoxantrone—lymphatic system cancer	0.000709	0.00223	CcSEcCtD
Nortriptyline—Rash—Fludarabine—lymphatic system cancer	0.000708	0.00222	CcSEcCtD
Nortriptyline—Dermatitis—Fludarabine—lymphatic system cancer	0.000707	0.00222	CcSEcCtD
Nortriptyline—Hypertension—Mitoxantrone—lymphatic system cancer	0.000707	0.00222	CcSEcCtD
Nortriptyline—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000704	0.00221	CcSEcCtD
Nortriptyline—Headache—Fludarabine—lymphatic system cancer	0.000703	0.00221	CcSEcCtD
Nortriptyline—Tachycardia—Carmustine—lymphatic system cancer	0.000701	0.0022	CcSEcCtD
Nortriptyline—Anxiety—Mitoxantrone—lymphatic system cancer	0.000694	0.00218	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000691	0.00217	CcSEcCtD
Nortriptyline—Discomfort—Mitoxantrone—lymphatic system cancer	0.000689	0.00216	CcSEcCtD
Nortriptyline—Oedema—Vincristine—lymphatic system cancer	0.000686	0.00216	CcSEcCtD
Nortriptyline—Anorexia—Carmustine—lymphatic system cancer	0.000685	0.00215	CcSEcCtD
Nortriptyline—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000678	0.00213	CcSEcCtD
Nortriptyline—Confusional state—Mitoxantrone—lymphatic system cancer	0.000674	0.00212	CcSEcCtD
Nortriptyline—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000672	0.00211	CcSEcCtD
Nortriptyline—Hypotension—Carmustine—lymphatic system cancer	0.000671	0.00211	CcSEcCtD
Nortriptyline—Oedema—Mitoxantrone—lymphatic system cancer	0.000668	0.0021	CcSEcCtD
Nortriptyline—Nausea—Fludarabine—lymphatic system cancer	0.000667	0.0021	CcSEcCtD
Nortriptyline—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000663	0.00208	CcSEcCtD
Nortriptyline—Shock—Mitoxantrone—lymphatic system cancer	0.000657	0.00207	CcSEcCtD
Nortriptyline—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000654	0.00206	CcSEcCtD
Nortriptyline—Urticaria—Bleomycin—lymphatic system cancer	0.000654	0.00206	CcSEcCtD
Nortriptyline—Anorexia—Vincristine—lymphatic system cancer	0.000654	0.00205	CcSEcCtD
Nortriptyline—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000652	0.00205	CcSEcCtD
Nortriptyline—Body temperature increased—Bleomycin—lymphatic system cancer	0.000651	0.00205	CcSEcCtD
Nortriptyline—Insomnia—Carmustine—lymphatic system cancer	0.00065	0.00204	CcSEcCtD
Nortriptyline—Irritability—Methotrexate—lymphatic system cancer	0.000646	0.00203	CcSEcCtD
Nortriptyline—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000646	0.00203	CcSEcCtD
Nortriptyline—Paraesthesia—Carmustine—lymphatic system cancer	0.000645	0.00203	CcSEcCtD
Nortriptyline—Hypotension—Vincristine—lymphatic system cancer	0.000641	0.00201	CcSEcCtD
Nortriptyline—Somnolence—Carmustine—lymphatic system cancer	0.000639	0.00201	CcSEcCtD
Nortriptyline—Anorexia—Mitoxantrone—lymphatic system cancer	0.000637	0.002	CcSEcCtD
Nortriptyline—Ataxia—Methotrexate—lymphatic system cancer	0.000637	0.002	CcSEcCtD
Nortriptyline—Decreased appetite—Carmustine—lymphatic system cancer	0.000625	0.00196	CcSEcCtD
Nortriptyline—Hypotension—Mitoxantrone—lymphatic system cancer	0.000624	0.00196	CcSEcCtD
Nortriptyline—Insomnia—Vincristine—lymphatic system cancer	0.00062	0.00195	CcSEcCtD
Nortriptyline—Paraesthesia—Vincristine—lymphatic system cancer	0.000616	0.00194	CcSEcCtD
Nortriptyline—Constipation—Carmustine—lymphatic system cancer	0.000614	0.00193	CcSEcCtD
Nortriptyline—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000607	0.00191	CcSEcCtD
Nortriptyline—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.0006	0.00189	CcSEcCtD
Nortriptyline—Decreased appetite—Vincristine—lymphatic system cancer	0.000596	0.00187	CcSEcCtD
Nortriptyline—Somnolence—Mitoxantrone—lymphatic system cancer	0.000594	0.00187	CcSEcCtD
Nortriptyline—Feeling abnormal—Carmustine—lymphatic system cancer	0.000592	0.00186	CcSEcCtD
Nortriptyline—Fatigue—Vincristine—lymphatic system cancer	0.000591	0.00186	CcSEcCtD
Nortriptyline—Asthenia—Bleomycin—lymphatic system cancer	0.000591	0.00186	CcSEcCtD
Nortriptyline—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000588	0.00185	CcSEcCtD
Nortriptyline—Constipation—Vincristine—lymphatic system cancer	0.000587	0.00184	CcSEcCtD
Nortriptyline—Pruritus—Bleomycin—lymphatic system cancer	0.000582	0.00183	CcSEcCtD
Nortriptyline—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000581	0.00183	CcSEcCtD
Nortriptyline—Eosinophilia—Methotrexate—lymphatic system cancer	0.00058	0.00182	CcSEcCtD
Nortriptyline—Fatigue—Mitoxantrone—lymphatic system cancer	0.000576	0.00181	CcSEcCtD
Nortriptyline—Constipation—Mitoxantrone—lymphatic system cancer	0.000571	0.0018	CcSEcCtD
Nortriptyline—Abdominal pain—Carmustine—lymphatic system cancer	0.000568	0.00179	CcSEcCtD
Nortriptyline—Body temperature increased—Carmustine—lymphatic system cancer	0.000568	0.00179	CcSEcCtD
Nortriptyline—Pancytopenia—Methotrexate—lymphatic system cancer	0.000556	0.00175	CcSEcCtD
Nortriptyline—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00055	0.00173	CcSEcCtD
Nortriptyline—Abdominal pain—Vincristine—lymphatic system cancer	0.000542	0.0017	CcSEcCtD
Nortriptyline—Body temperature increased—Vincristine—lymphatic system cancer	0.000542	0.0017	CcSEcCtD
Nortriptyline—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.000539	0.00169	CcSEcCtD
Nortriptyline—Urticaria—Mitoxantrone—lymphatic system cancer	0.000531	0.00167	CcSEcCtD
Nortriptyline—Hypersensitivity—Carmustine—lymphatic system cancer	0.000529	0.00166	CcSEcCtD
Nortriptyline—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000528	0.00166	CcSEcCtD
Nortriptyline—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000528	0.00166	CcSEcCtD
Nortriptyline—Vomiting—Bleomycin—lymphatic system cancer	0.000523	0.00164	CcSEcCtD
Nortriptyline—Drowsiness—Methotrexate—lymphatic system cancer	0.000522	0.00164	CcSEcCtD
Nortriptyline—Rash—Bleomycin—lymphatic system cancer	0.000519	0.00163	CcSEcCtD
Nortriptyline—Dermatitis—Bleomycin—lymphatic system cancer	0.000519	0.00163	CcSEcCtD
Nortriptyline—Asthenia—Carmustine—lymphatic system cancer	0.000516	0.00162	CcSEcCtD
Nortriptyline—Stomatitis—Methotrexate—lymphatic system cancer	0.000509	0.0016	CcSEcCtD
Nortriptyline—Hypersensitivity—Vincristine—lymphatic system cancer	0.000505	0.00159	CcSEcCtD
Nortriptyline—Sweating—Methotrexate—lymphatic system cancer	0.0005	0.00157	CcSEcCtD
Nortriptyline—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000492	0.00155	CcSEcCtD
Nortriptyline—Asthenia—Vincristine—lymphatic system cancer	0.000492	0.00155	CcSEcCtD
Nortriptyline—Diarrhoea—Carmustine—lymphatic system cancer	0.000492	0.00155	CcSEcCtD
Nortriptyline—Nausea—Bleomycin—lymphatic system cancer	0.000489	0.00154	CcSEcCtD
Nortriptyline—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000487	0.00153	CcSEcCtD
Nortriptyline—Asthenia—Mitoxantrone—lymphatic system cancer	0.000479	0.00151	CcSEcCtD
Nortriptyline—Dizziness—Carmustine—lymphatic system cancer	0.000475	0.00149	CcSEcCtD
Nortriptyline—Diarrhoea—Vincristine—lymphatic system cancer	0.000469	0.00147	CcSEcCtD
Nortriptyline—Hepatitis—Methotrexate—lymphatic system cancer	0.000468	0.00147	CcSEcCtD
Nortriptyline—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000457	0.00144	CcSEcCtD
Nortriptyline—Vomiting—Carmustine—lymphatic system cancer	0.000457	0.00144	CcSEcCtD
Nortriptyline—Dizziness—Vincristine—lymphatic system cancer	0.000454	0.00143	CcSEcCtD
Nortriptyline—Rash—Carmustine—lymphatic system cancer	0.000453	0.00142	CcSEcCtD
Nortriptyline—Dermatitis—Carmustine—lymphatic system cancer	0.000453	0.00142	CcSEcCtD
Nortriptyline—Headache—Carmustine—lymphatic system cancer	0.00045	0.00141	CcSEcCtD
Nortriptyline—Eye disorder—Methotrexate—lymphatic system cancer	0.000438	0.00138	CcSEcCtD
Nortriptyline—Tinnitus—Methotrexate—lymphatic system cancer	0.000437	0.00137	CcSEcCtD
Nortriptyline—Vomiting—Vincristine—lymphatic system cancer	0.000436	0.00137	CcSEcCtD
Nortriptyline—Rash—Vincristine—lymphatic system cancer	0.000433	0.00136	CcSEcCtD
Nortriptyline—Dermatitis—Vincristine—lymphatic system cancer	0.000432	0.00136	CcSEcCtD
Nortriptyline—Headache—Vincristine—lymphatic system cancer	0.00043	0.00135	CcSEcCtD
Nortriptyline—Nausea—Carmustine—lymphatic system cancer	0.000427	0.00134	CcSEcCtD
Nortriptyline—Vomiting—Mitoxantrone—lymphatic system cancer	0.000425	0.00133	CcSEcCtD
Nortriptyline—Rash—Mitoxantrone—lymphatic system cancer	0.000421	0.00132	CcSEcCtD
Nortriptyline—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000421	0.00132	CcSEcCtD
Nortriptyline—Headache—Mitoxantrone—lymphatic system cancer	0.000418	0.00132	CcSEcCtD
Nortriptyline—Alopecia—Methotrexate—lymphatic system cancer	0.000414	0.0013	CcSEcCtD
Nortriptyline—Nausea—Vincristine—lymphatic system cancer	0.000407	0.00128	CcSEcCtD
Nortriptyline—Dysgeusia—Methotrexate—lymphatic system cancer	0.000399	0.00126	CcSEcCtD
Nortriptyline—Nausea—Mitoxantrone—lymphatic system cancer	0.000397	0.00125	CcSEcCtD
Nortriptyline—Vision blurred—Methotrexate—lymphatic system cancer	0.000384	0.00121	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000378	0.00119	CcSEcCtD
Nortriptyline—Malaise—Methotrexate—lymphatic system cancer	0.000368	0.00116	CcSEcCtD
Nortriptyline—Leukopenia—Methotrexate—lymphatic system cancer	0.000365	0.00115	CcSEcCtD
Nortriptyline—Convulsion—Methotrexate—lymphatic system cancer	0.000353	0.00111	CcSEcCtD
Nortriptyline—Discomfort—Methotrexate—lymphatic system cancer	0.000343	0.00108	CcSEcCtD
Nortriptyline—Confusional state—Methotrexate—lymphatic system cancer	0.000336	0.00105	CcSEcCtD
Nortriptyline—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000326	0.00102	CcSEcCtD
Nortriptyline—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.000322	0.00101	CcSEcCtD
Nortriptyline—Anorexia—Methotrexate—lymphatic system cancer	0.000317	0.000997	CcSEcCtD
Nortriptyline—Hypotension—Methotrexate—lymphatic system cancer	0.000311	0.000977	CcSEcCtD
Nortriptyline—Insomnia—Methotrexate—lymphatic system cancer	0.000301	0.000946	CcSEcCtD
Nortriptyline—Paraesthesia—Methotrexate—lymphatic system cancer	0.000299	0.000939	CcSEcCtD
Nortriptyline—Somnolence—Methotrexate—lymphatic system cancer	0.000296	0.00093	CcSEcCtD
Nortriptyline—Dyspepsia—Methotrexate—lymphatic system cancer	0.000293	0.000921	CcSEcCtD
Nortriptyline—Decreased appetite—Methotrexate—lymphatic system cancer	0.000289	0.000909	CcSEcCtD
Nortriptyline—Fatigue—Methotrexate—lymphatic system cancer	0.000287	0.000902	CcSEcCtD
Nortriptyline—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000274	0.000862	CcSEcCtD
Nortriptyline—Urticaria—Methotrexate—lymphatic system cancer	0.000264	0.000831	CcSEcCtD
Nortriptyline—Abdominal pain—Methotrexate—lymphatic system cancer	0.000263	0.000827	CcSEcCtD
Nortriptyline—Body temperature increased—Methotrexate—lymphatic system cancer	0.000263	0.000827	CcSEcCtD
Nortriptyline—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000245	0.000771	CcSEcCtD
Nortriptyline—Asthenia—Methotrexate—lymphatic system cancer	0.000239	0.00075	CcSEcCtD
Nortriptyline—Pruritus—Methotrexate—lymphatic system cancer	0.000235	0.00074	CcSEcCtD
Nortriptyline—Diarrhoea—Methotrexate—lymphatic system cancer	0.000228	0.000716	CcSEcCtD
Nortriptyline—Dizziness—Methotrexate—lymphatic system cancer	0.00022	0.000692	CcSEcCtD
Nortriptyline—Vomiting—Methotrexate—lymphatic system cancer	0.000212	0.000665	CcSEcCtD
Nortriptyline—Rash—Methotrexate—lymphatic system cancer	0.00021	0.00066	CcSEcCtD
Nortriptyline—Dermatitis—Methotrexate—lymphatic system cancer	0.00021	0.000659	CcSEcCtD
Nortriptyline—Headache—Methotrexate—lymphatic system cancer	0.000209	0.000655	CcSEcCtD
Nortriptyline—Nausea—Methotrexate—lymphatic system cancer	0.000198	0.000621	CcSEcCtD
